Syed M Khurram Owais, MD
Anesthesiology · Boston, MANPI 1083096358
Payments from drug & device makers
Across 137 payments — averaging $72.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- SPR Therapeutics, Inc$2K
- Abbott$2K
- Medtronic$861
- Nevro Corp.$790
- Vertos Medical, Inc.$126
- plus $394 from 11 others
What the payments were for
- Travel & lodging$5,19252%
- Food & beverage$4,74348%
- Education$440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 25 | $3,937 |
| SPR Therapeutics, Inc | 38 | $2,199 |
| Abbott | 15 | $1,672 |
| Medtronic(2 entities) | 26 | $861 |
| Nevro Corp. | 12 | $790 |
| Vertos Medical, Inc. | 5 | $126 |
| Painteq LLC | 3 | $87 |
| Curonix LLC | 2 | $48 |
| Relievant Medsystems, Inc. | 2 | $45 |
| MML US, Inc. | 2 | $43 |
| Stryker | 1 | $35 |
| Stimwave Technologies Incorporated | 1 | $29 |
| GRT US Holding, Inc. | 1 | $28 |
| Globus Medical | 1 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Pfizer | 1 | $19 |
| Avanos Medical | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion Indirect Decompression System$1,551
- SPRINT PNS System$1,381
- Proclaim Family of SCS IPGs$1,139
- Intracept$1,035
- SPECTRA WAVEWRITER$744
- Senza Spinal Cord Stimulation System$393
- RESTORE$119
- Senza$113
- Axium INS DRG IPG$111
How this compares
$9,978 in reported general payments places this provider in the 95th percentile of 1,585 anesthesiology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 82 | $934 |
| Pregabalin | 39 | $621 |
| Lidocaine | 11 | $585 |
| Tizanidine Hcl | 23 | $485 |
| Methocarbamol | 27 | $449 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $230 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $202 |
| Cyclobenzaprine Hcl | 14 | $163 |
| Tramadol Hcl | 27 | $76 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Boston
- Mathias EikermannBoston$461K
- Robert YongBoston$459K
- Lorenzo BerraBoston$437K
- Timothy DelsolBoston$389K
- Edgar RossBoston$377K
- Maximilian SchaeferBoston$320K
- Victor WangBoston$294K
- Douglas ShookBoston$267K
- Gyorgy FrendlBoston$261K
- Michael DambraBoston$194K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.